Breathing monitor that can deliver 45 minute cardiac arrest warning gets European go-ahead
The respiR8™ breathing rate counter for hospitals has received the CE mark, enabling it to be used throughout Europe. The device, from UK-based Anaxsys, is novel as it measures the moisture in a patient’s breath and could transform the way that patients are monitored after anaesthetic or opioid pain relief as it alerts the healthcare professional to respiratory depression. By providing continuous breathing rate monitoring, respiR8™ can give an early warning should a patient deteriorate. A low breathing rate can warn of a respiratory arrest whereas rapid breathing over 27 breaths per minute, provides a warning of a potential cardiac arrest or infection.